Hikma Pharmaceutical | HIK - Operating Profit



Hikma Pharmaceutical reported $201M in Operating Profit for its fiscal semester ending in June of 2024.

Operating Profit Change Date
Almirall EUR 53.03M 68.53M Jun/2024
argenx SE USD 16.17M 60.11M Sep/2024
AstraZeneca USD 2.77B 133M Sep/2024
Autolus Therapeutics Ltd -67876000 8.95M Sep/2024
Bayer EUR -3822000000 4.35B Sep/2024
Fresenius EUR 492M 227M Sep/2024
Galapagos EUR -54305000 16.12M Sep/2024
Genmab DKK 2.1B 286M Sep/2024
GlaxoSmithKline GBP 189M 2.03B Sep/2024
GRIFOLS EUR 252.41M 165.63M Jun/2024
Hikma Pharmaceutical USD 201M 82M Jun/2024
Lonza CHF 534M 194M Jun/2024
Merck EUR 793M 137M Jun/2024
Orion EUR 202M 136.3M Sep/2024
Recordati EUR 148.86M 42.92M Jun/2024
Roche Holding CHF 5.42B 21.5M Jun/2024
Sanofi EUR 4.09B 1.81B Sep/2024
UCB EUR 163M 39M Jun/2024